# Paclitaxel

NDC: 0480-3290
Generic name: Paclitaxel
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20240702

FDA application: NDA216338

## Active ingredients

- PACLITAXEL: 100 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-3290"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-3290
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15dd51ed-29e8-468b-b6d1-21b1f84d6f2e